APA (7th ed.) Citation

Bastholt, L., Svane, I. M., Bjerregaard, J. K., Herrstedt, J., Hróbjartsson, A., & Schmidt, H. (2019). High-dose interleukin-2 and interferon as first-line immunotherapy for metastatic melanoma: Long-term follow-up in a large unselected Danish patient cohort. European Journal of Cancer, 115, 61. https://doi.org/10.1016/j.ejca.2019.03.023

Chicago Style (17th ed.) Citation

Bastholt, Lars, Inge Marie Svane, Jon Kroll Bjerregaard, Jørn Herrstedt, Asbjørn Hróbjartsson, and Henrik Schmidt. "High-dose Interleukin-2 and Interferon as First-line Immunotherapy for Metastatic Melanoma: Long-term Follow-up in a Large Unselected Danish Patient Cohort." European Journal of Cancer 115 (2019): 61. https://doi.org/10.1016/j.ejca.2019.03.023.

MLA (9th ed.) Citation

Bastholt, Lars, et al. "High-dose Interleukin-2 and Interferon as First-line Immunotherapy for Metastatic Melanoma: Long-term Follow-up in a Large Unselected Danish Patient Cohort." European Journal of Cancer, vol. 115, 2019, p. 61, https://doi.org/10.1016/j.ejca.2019.03.023.